Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor

SU Zhigui; MO Ran; ZHANG Can

doi:10.11665/j.issn.1000-5048.20150103

Journal of China Pharmaceutical University > 2015 > 46(1): 28-39. > DOI: 10.11665/j.issn.1000-5048.20150103

SU Zhigui, MO Ran, ZHANG Can. Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J]. Journal of China Pharmaceutical University, 2015, 46(1): 28-39. DOI: 10.11665/j.issn.1000-5048.20150103

Citation:

PDF (1036 KB)

Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor

More Information

Graphical Abstract

Abstract

Abstract

Nano-drug delivery systems(nano-DDSs)play an important role in targeted cancer therapy. Due to the physiological characteristics of the body and the heterogenicity of tumor, intravenous delivery of anticancer agents carried by nano-DDSs from the injection site to their targeted sites is required to overcome multiple physiological and pathological barriers, including blood, tumor tissue, tumor cell and intracellular transportation. This review surveys emerging strategies for the development of novel nano-DDSs that can conquer the physiological and pathological barriers of tumor, which provides a great potential platform for safe and efficient cancer treatment.
- nano-drug delivery systems,
- physiological and pathological barriers,
- tumor microenvironment,
- in situ response,
- targeted therapy

FullText(HTML)

References (71)

References

[1]	Kim JK,Howard MD,Dziubla TD,et al.Uniformity of drug payload and its effect on stability of solid lipid nanoparticles containing an ester prodrug[J].ACS Nano,2011,5(1):209-216.
[2]	Sun C,Du K,Fang C,et al.PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles:their physicochemical properties and function in vivo[J].ACS Nano,2010,4(4):2402-2410.
[3]	Sandiford L,Phinikaridou A,Protti A,et al.Bisphosphonate-anchored PEGylation and radiolabeling of superparamagnetic iron oxide:long-circulating nanoparticles for in vivo multimodal(T1 MRI-SPECT)imaging[J].ACS Nano,2013,7(1):500-512.
[4]	Han J,Wang Q,Zhang Z,et al.Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer[J].Small,2014,10(3):524-535.
[5]	Dolman ME,Harmsen S,Storm G,et al.Drug targeting to the kidney:advances in the active targeting of therapeutics to proximal tubular cells[J].Adv Drug Deliv Rev,2010,62(14):1344-1357.
[6]	Liu Y,Hu Y,Huang L.Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles[J].Biomaterials,2014,35(9):3027-3034.
[7]	Sadzuka Y,Nakade A,Tsuruda T,et al.Study on the characterization of mixed polyethyleneglycol modified liposomes containing doxorubicin[J].J Control Release,2003,91(3):271-280.
[8]	Li SD,Huang L.Stealth nanoparticles:high density but sheddable PEG is a key for tumor targeting[J].J Control Release,2010,145(3):178-181.
[9]	Zhang J,Li X,Huang L.Non-viral nanocarriers for siRNA delivery in breast cancer[J].J Control Release,2014,190:440-450.
[10]	Mishra S,Webster P,Davis ME.PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles[J].Eur J Cell Biol,2004,83(3):97-111.
[11]	Shiraishi K,Hamano M,Ma H,et al.Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance(ABC)phenomenon[J].J Control Release,2013,165(3):183-190.
[12]	Abu Lila AS,Kiwada H,Ishida T.The accelerated blood clearance(ABC)phenomenon:clinical challenge and approaches to manage[J].J Control Release,2013,172(1):38-47.
[13]	Wang YZ,Zhou JP,Ding Y,et al.Advances in research of biomimetic drug delivery systems[J].J China Pharm Univ(中国药科大学学报),2014,45(3):267-273.
[14]	Zhu Q,Jia L,Gao Z,et al.A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy[J].Mol Pharm,2014,11(10):3269-3278.
[15]	Wu J,Song C,Jiang C,et al.Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery[J].Mol Pharm,2013,10(10):3555-3563.
[16]	Cormode DP,Skajaa T,van Schooneveld MM,et al.Nanocrystal core high-density lipoproteins:a multimodality contrast agent platform[J].Nano Lett,2008,8(11):3715-3723.
[17]	Kim HR,Gil S,Andrieux K,et al.Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells[J].Cell Mol Life Sci,2007,64(3):356-364.
[18]	Reynolds L, Mulik RS, Wen X, et al. Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells[J].Nanomedicine(Lond),2014,9(14):2123-2141.
[19]	Allijn IE, Leong W, Tang J, et al. Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level[J].ACS Nano,2013,7(11):9761-9770.
[20]	Lee JY,Kim JH,Bae KH,et al.Low-density lipoprotein-mimicking nanoparticles for tumor-targeted theranostic applications[J].Small,2014.dio:10.1002/smll.201303277.
[21]	Glickson JD,Lund-Katz S,Zhou R,et al.Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents[J].Adv Exp Med Biol,2009,645:227-239.
[22]	Tsai RK,Rodriguez PL,Discher DE.Self inhibition of phagocytosis:the affinity of ‘marker of self’ CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels[J].Blood Cells Mol Dis,2010,45(1):67-74.
[23]	Hu CM,Zhang L,Aryal S,et al.Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform[J].Proc Natl Acad Sci U S A,2011,108(27):10980-10985.
[24]	Hu CM,Fang RH,Luk BT,et al.Nanoparticle-detained toxins for safe and effective vaccination[J].Nat Nanotechnol,2013,8(12):933-938.
[25]	Hu CM,Fang RH,Copp J,et al.A biomimetic nanosponge that absorbs pore-forming toxins[J].Nat Nanotechnol,2013,8(5):336-340.
[26]	Copp JA,Fang RH,Luk BT,et al.Clearance of pathological antibodies using biomimetic nanoparticles[J].Proc Natl Acad Sci U S A,2014,111(37):13481-13486.
[27]	Gao W,Hu CM,Fang RH,et al.Surface functionalization of gold nanoparticles with red blood cell membranes[J].Adv Mater,2013,25(26):3549-3553.
[28]	Parodi A,Quattrocchi N,van de Ven AL,et al.Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions[J].Nat Nanotechnol,2013,8(1):61-68.
[29]	Banz A,Cremel M,Mouvant A,et al.Tumor growth control using red blood cells as the antigen delivery system and poly(I:C)[J].J Immunother,2012,35(5):409-417.
[30]	Muthana M,Giannoudis A,Scott SD,et al.Use of macrophages to target therapeutic adenovirus to human prostate tumors[J].Cancer Res,2011,71(5):1805-1815.
[31]	Huang X,Zhang F,Wang Y,et al.Design considerations of iron-based nanoclusters for noninvasive tracking of mesenchymal stem cell homing[J].ACS Nano,2014,8(5):4403-4414.
[32]	Anselmo AC,Gupta V,Zern BJ,et al.Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells[J].ACS Nano,2013,7(12):11129-11137.
[33]	Cheng H,Kastrup CJ,Ramanathan R,et al.Nanoparticulate cellular patches for cell-mediated tumoritropic delivery[J].ACS Nano,2010,4(2):625-631.
[34]	Doshi N,Swiston AJ,Gilbert JB,et al.Cell-based drug delivery devices using phagocytosis-resistant backpacks[J].Adv Mater,2011,23(12):H105-H109.
[35]	Cabral H,Matsumoto Y,Mizuno K,et al.Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size[J].Nat Nanotechnol,2011,6(12):815-823.
[36]	Tang L, Yang X, Yin Q, et al. Investigating the optimal size of anticancer nanomedicine[J].Proc Natl Acad Sci U S A,2014,111(43):15344-15349.
[37]	Guo S,Lin CM,Xu Z,et al.Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation[J].ACS Nano,2014,8(5):4996-5009.
[38]	Pietras K,Rubin K,Sjoblom T,et al.Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy[J].Cancer Res,2002,62(19):5476-5484.
[39]	Zhang J,Miao L,Guo S,et al.Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model[J].J Control Release,2014,182:90-96.
[40]	Guo S,Wang Y,Miao L,et al.Lipid-coated cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy[J].ACS Nano,2013,7(11):9896-9904.
[41]	Ju C,Mo R,Xue J,et al.Sequential intra-intercellular nanoparticle delivery system for deep tumor penetration[J].Angew Chem Int Ed Engl,2014,53(24):6253-6258.
[42]	Wang X,Yang C,Zhang Y,et al.Delivery of platinum(IV)drug to subcutaneous tumor and lung metastasis using bradykinin-potentiating peptide-decorated chitosan nanoparticles[J].Biomaterials,2014,35(24):6439-6453.
[43]	Nomoto T, Matsumoto Y, Miyata K, et al. In situ quantitative monitoring of polyplexes and polyplex micelles in the blood circulation using intravital real-time confocal laser scanning microscopy[J].J Control Release,2011,151(2):104-109.
[44]	Abu Lila AS,Doi Y,Nakamura K,et al.Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor[J].J Control Release,2010,142(2):167-173.
[45]	Tian L,Bae YH.Cancer nanomedicines targeting tumor extracellular pH[J].Colloids Surf B Biointerfaces,2012,99:116-126.
[46]	Ding C,Gu J,Qu X,et al.Preparation of multifunctional drug carrier for tumor-specific uptake and enhanced intracellular delivery through the conjugation of weak acid labile linker[J].Bioconjug Chem,2009,20(6):1163-1170.
[47]	Gao Y,Ma R,An Y,et al.Nanogated vessel based on polypseudorotaxane-capped mesoporous silica via a highly acid-labile benzoic-imine linker[J].J Control Release,2011,152(Suppl 1):e81-82.
[48]	Wang J,Gong C,Wang Y,et al.Magnetic nanoparticles with a pH-sheddable layer for antitumor drug delivery[J].Colloids Surf B Biointerfaces,2014,118:218-225.
[49]	Yang XZ,Du JZ,Dou S,et al.Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery[J].ACS Nano,2012,6(1):771-781.
[50]	Song N,Ding M,Pan Z,et al.Construction of targeting-clickable and tumor-cleavable polyurethane nanomicelles for multifunctional intracellular drug delivery[J].Biomacromolecules,2013,14(12):4407-4419.
[51]	Zhang J,Yuan ZF,Wang Y,et al.Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery[J].J Am Chem Soc,2013,135(13):5068-5073.
[52]	Zhu L,Wang T,Perche F,et al.Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety[J].Proc Natl Acad Sci U S A,2013,110(42):17047-17052.
[53]	Stern R. Hyaluronidases in cancer biology[J]. Semin Cancer Biol,2008,18(4):275-280.
[54]	Jiang T,Zhang Z,Zhang Y,et al.Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery[J].Biomaterials,2012,33(36):9246-9258.
[55]	Jiang T, Mo R, Bellotti A, et al. Gel-liposome-mediated co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacy[J].Adv Funct Mater,2013,24(16):2295-2304.
[56]	Neuberg P, Kichler A. Recent developments in nucleic acid delivery with polyethylenimines[J].Adv Genet,2014,88:263-288.
[57]	Ouyang D,Zhang H,Parekh HS,et al.The effect of pH on PAMAM dendrimer-siRNA complexation:endosomal considerations as determined by molecular dynamics simulation[J].Biophys Chem,2011,158(2/3):126-133.
[58]	Lachelt U,Kos P,Mickler FM,et al.Fine-tuning of proton sponges by precise diaminoethanes and histidines in pDNA polyplexes[J].Nanomedicine,2014,10(1):35-44.
[59]	Ihm JE,Han KO,Han IK,et al.High transfection efficiency of poly(4-vinylimidazole)as a new gene carrier[J].Bioconjug Chem,2003,14(4):707-708.
[60]	Kim HJ,Takemoto H,Yi Y,et al.Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles[J].ACS Nano,2014,8(9):8979-8991.
[61]	Yang Y,Hu Y,Wang Y,et al.Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer[J].Mol Pharm,2012,9(8):2280-2289.
[62]	Xu Z,Wang Y,Zhang L,et al.Nanoparticle-delivered transforming growth factor-beta siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment[J].ACS Nano,2014,8(4):3636-3645.
[63]	Ke CJ, Su TY, Chen HL, et al. Smart multifunctional hollow microspheres for the quick release of drugs in intracellular lysosomal compartments[J].Angew Chem Int Ed Engl,2011,50(35):8086-8089.
[64]	Lee ES,Kim D,Youn YS,et al.A virus-mimetic nanogel vehicle[J].Angew Chem Int Ed Engl,2008,47(13):2418-2421.
[65]	Griset AP,Walpole J,Liu R,et al.Expansile nanoparticles:synthesis,characterization,and in vivo efficacy of an acid-responsive polymeric drug delivery system[J].J Am Chem Soc,2009,131(7):2469-2471.
[66]	Hafez IM,Maurer N,Cullis PR.On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids[J].Gene Ther,2001,8(15):1188-1196.
[67]	Li S,Su Z,Sun M,et al.An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery[J].Int J Pharm,2012,436(1/2):248-257.
[68]	Yessine MA, Leroux JC. Membrane-destabilizing polyanions:interaction with lipid bilayers and endosomal escape of biomacromolecules[J].Adv Drug Deliv Rev,2004,56(7):999-1021.
[69]	Mebarek N, Aubert-Pouessel A, Gerardin C, et al. Polymeric micelles based on poly(methacrylic acid)block-containing copolymers with different membrane destabilizing properties for cellular drug delivery[J].Int J Pharm,2013,454(2):611-620.
[70]	Mochizuki S,Kanegae N,Nishina K,et al.The role of the helper lipid dioleoylphosphatidylethanolamine(DOPE)for DNA transfection cooperating with a cationic lipid bearing ethylenediamine[J].Biochim Biophys Acta,2013,1828(2):412-418.
[71]	Lin SY,Zhao WY,Tsai HC,et al.Sterically polymer-based liposomal complexes with dual-shell structure for enhancing the siR

Cited By

Get Citation

PDF

XML

Article views (2110) PDF downloads (4688)

Turn off MathJax

Article Contents

Abstract

References

Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor

Abstract

References

Catalog

Export File

Citation

Format

Content